In the search for alternative non-metabolizable inducers in the L-rhamnose promoter system, the synthesis of fifteen 6-deoxyhexoses from L-rhamnose demonstrates the value of synergy between biotechnology and chemistry. The readily available 2,3-acetonide of rhamnonolactone allows inversion of configuration at C4 and/or C5 of rhamnose to give 6-deoxy-D-allose, 6-deoxy-D-gulose and 6-deoxy-L-talose. Highly crystalline 3,5-benzylidene rhamnonolactone gives easy access to Lquinovose [6-deoxy-L-glucose], L-olivose and rhamnose analogue with C2 azido, amino and acetamido substituents. Electrophilic fluorination of rhamnal gives a mixture of 2-deoxy-2-fluoro-Lrhamnose and 2-deoxy-2-fluoro-L-quinovose. Biotechnology provides access to 6-deoxy-L-altrose and 1-deoxy-L-fructose.
INTRODUCTION
In biotechnology, control over gene expression is often useful, such as in the production of proteins of interest. This is typically achieved by assembling a DNA construct in which the gene of interest is placed under the control of a promoter (a regulatory DNA sequence) which responds to a known external stimulus. Numerous inducible gene expression systems have been reported, exploiting inducible promoters which respond to natural or synthetic stimuli such as sugars, antibiotics and metals. [1] L-Rhamnose [6-deoxy-L-mannose] is readily metabolized by E. coli [2] and the metabolism of L-rhamnose is precisely controlled. L-Rhamnose works as inducer of the operon encoding the enzymes required for its metabolism, rhaBAD.
[3] The L-rhamnose promoter system, P rhaBAD , is used extensively for the heterologous expression of many genes of interest in E. coli and other bacteria.
[4]
Its many advantages over alternative promoter systems include: non-leaky basal expression, titratable concentration-dependent expression and the ability to achieve higher levels of expression. [5] However, due to L-rhamnose metabolism and its auto-repression of the P rhaBAD promoter, [6] induction is transient, which limits its application. This system could be improved by the development of a nonmetabolizable analogue of L-rhamnose, an approach which has been developed for only a few other inducible expression systems. [7] No 6-deoxyhexose analogues have been tested for this purpose previously.
The chemotherapeutic potential of interfering with L-rhamnose metabolic pathways in bacteria and in plants has long been recognized, and is safe because L-rhamnose has no role in mammalian metabolism. [ 8 ] Synthetic inducers/antagonists of the rhamnose operon might also be useful as antimicrobials, targeting pathogens requiring rhamnose-incorporation into their cell walls for survival. Control or suppression of expression of the genes encoding rhamnose metabolic enzymes may allow control of biosynthesis of TDP-rhamnose and thus of cell wall construction of a number of pathogens. [ 9 ] For example, a rhamnose inducible promoter was reported to be essential to Burkholderia cenocepacia. [10] Other L-rhamnose metabolic enzymes, such as L-rhamnosidases and Lrhamnose isomerase, are also potential targets. Iminosugars affecting rhamnose processing enzymes may have potential as antibiotics.
[11] The identification of synthetic inducers or antagonists of the Lrhamnose metabolic pathway will be valuable tools for biotechnology. [14] is easy neither to set up the precursor nor to perform S N 2 displacements of sulfonates.
However efficient S N 2 reactions in rhamnonolactones can allow isomerization at C5, C4 and C2. The 2,3-acetonide of rhamnonolactone 2 is readily available from L-rhamnose in multigram scale by a well-established procedure.
[15 ] Lactone 2 allows access to the 3 diastereomeric lactols 3-5 as intermediates in the synthesis of 6-deoxy-D-gulose 6, 6-deoxy-D-allose 7 and 6-deoxy-L-talose 8 (strategy A). Unlike many lactone acetonides, 2 is not crystalline and is usually contaminated with the corresponding 3,5-acetonide. The highly crystalline benzylidene lactone 9, with only C2 OH free, was prepared from L-rhamnose on a 50 g scale by a reported procedure (strategy B). [16] High yield nucleophilic substitution of the epimeric manno-10 and gluco-11 C2 triflates allowed the syntheses of the epimer at C2 L-quinovose 12, the dideoxy hexose L-olivose 13 and both epimers of analogues with nitrogen introduced at C2 14; 2-nitrogen substituted analogues are also useful building blocks for the synthesis of bioactive glycoconjugates. [17] It was not possible to introduce fluorine at C2 by an S N 2 reaction; strategy C uses diacetyl rhamnal 15 for the non-stereoselective introduction of electrophilic fluorine to allow access to the 2-fluoro analogues of rhamnose 16 and quinovose 17. It is not easy to access C3 of rhamnonolactone (or rhamnose) chemically; [18] however, a highly efficient biotechnological synthesis of the C3 epimer 18 allows the preparation of multigram quantities (strategy D). Rhamnose may also be converted to 19 where the anomeric hydroxyl group has been transposed from C1 to C5. Thus a combination of biotechnology and chemistry has allowed the preparation of some 15 analogues of rhamnose as free sugars for evaluation as inducers of the rhamnose operon. The acetonide of rhamnonolactone 2 allowed easy access to three diastereomeric lactones at C4 and C5 22, 24 and 26 [Scheme 2]. There are very few examples of S N 2 reactions [19] at C5 of 2. The difficulty probably arises from the extra steric hindrance because of the cis-relationship of the isopropylidene protecting group and the C4-side chain; S N 2 displacements at C5 of the C4-epimeric talono-lactone 24, where there is a corresponding trans arrangement, are efficient. [20] All attempts to use oxygen nucleophiles [acetate or trifluoroacetate in DMF, butanone or pentanone] on either the mesylate 23 or the corresponding triflate gave no indication of the formation of the gulo-epimer 22. Accordingly, inversion of configuration at C5 was achieved by Dess-Martin oxidation of 2 in dichloromethane to give the crystalline ketone 21 (77%). Reduction of 21 with sodium borohydride ar room temperature showed little diastereoselectivity to give crystalline 22 [21] (54%) and the D-gulolactone 2 in a 1.5:1 ratio. No improvement in the ratio was found at lower temperatures or use of cyanoborohydride and other conditions led to competitive reduction of the lactone; a similar lack diastereoselectivity has been found in analogous systems. [22] The two lactones 2 and 22 were readily separable by chromatography. Reduction of 22 with diisobutylaluminum hydride (DIBALH) in dichloromethane afforded the lactols 3 (75%). In the reduction of 2,3-protected lactones, no attempts were made to analyze the ratio of 2,3-O-isopropylidene pyranoses and furanoses formed. Acid ion exchange catalyzed hydrolysis of the lactols at room temperature gave 6-deoxy-D-gulose 6 [23] , a syrup, (93%) predominantly as the β-pyranose form.
SYNTHESIS
Esterification of the free alcohol in 2 with mesyl chloride in pyridine gave the mesylate 23 (83%); treatment of 23 with aqueous potassium hydroxide in 1,4-dioxane caused inversion of configuration at both C4 and C5 by Payne rearrangements [24] to form the D-allono-lactone 24 (79%). Nucleophilic displacement at C5 of the allono-lactone 24 where the side chain is trans to the isopropylidene protecting group was efficient. Thus reaction of 24 with triflic anhydride in dichloromethane in the presence of pyridine gave the corresponding triflate 25 which, with sodium trifluoroacetate in pentanone at room temperature followed by work-up with methanol, [25] gave the talono-lactone 26 in 70% yield. DMF is not an appropriate solvent since the solvent competes with trifluoroacetate as a nucleophile; the mesylate of 24 did not give S N displacement by trifluoroacetate.
An identical two-step procedure for the reduction and hydrolysis of the protected allono-24 and talono-26 lactones gave 6-deoxy-D-allose 7 [26] and 6-deoxy-L-talose 8 [27] , in overall yields of 83% and 72%, via the lactols 4 and 5 respectively.
For the rhamnose operon assays, it was very important to establish that there was no contamination of 6-deoxy-D-gulose 6 with rhamnose arising from incomplete separation of 2 and 22 in the reduction of ketone 21. Accordingly, an alternative approach to 6-deoxy-gulonolactone 22 by a double inversion of C4 and C5 of the talono-lactone 26 was investigated. Sequential formation of the mesylate 27 from 26, followed by treatment with aqueous potassium, hydroxide gave 22 in 76% which was identical to that prepared from the reduction of the ketone 21. A sample of 6-deoxy-D-gulose 6 by this route gave an identical response in the rhamnose operon experiments to that derived from the ketone; [12] The highly crystalline benzylidene lactone 9 was directly obtained from rhamnose on a 50 g scale as previously described. [28] Esterification of the C2-OH group in 9 with triflic anhydride in THF afforded the triflate 10 [16] which is an ideal intermediate for S N 2 reactions at C2 of rhamnose.
Although the crude triflate 10 may be used directly in subsequent reactions, 10 is a stable triflate which can be purified by column chromatography. For the preparation of L-quinovose [6-deoxy-Lglucose] 12, reaction of 10 with cesium trifluoroacetate in butanone [29] gave the inverted alcohol 28 16 (90%) [Scheme 3]. Attempts to reduce 28 directly gave complex mixtures but prior protection of 28 with TBDMS chloride in DMF in the presence of imidazole afforded the TBDMS ether 29 (71%); DIBALH reduction of the fully protected lactone 29 formed the protected lactols 30 (88%). Removal of the silyl and benzylidene protecting groups in 30 by ion exchange gave L-quinovose 12 [30] (100%) with an identical 1 H NMR spectrum to that of an authentic sample of D-quinovose [see SI].
Treatment of the triflate 10 with lithium iodide hydrate in butanone gave the iodide 31 by rapid S N 2 displacement of the triflate which underwent further attack by iodide to give iodine [31] and the deoxygenated lactone 32 (74%). Reduction of 32 by DIBALH in dichloromethane afforded the lactols 33 (96%) which on hydrolysis by acid ion exchange resin gave L-olivose 13 [32] (100%). In a number of cases it has been established that azide displacement of a triflate at C2 of a lactone may result in isolation of the azide with either retention or inversion of configuration. [25, 33] [34] (98%). Hydrogenation of the azide 35 in the presence of acetic anhydride and palladium in ethyl acetate/1,4-dioxane gave the protected gluco-acetamide 40 (74%). Removal of the benzylidene acetal in 40 by DOWEX-catalysed hydrolysis in aqueous ethanol afforded acetamido-quinovose 41 [34] (90%). Identical procedures on the rhamno-azide 37 gave the azido-42 (95%), amino-43 [34] (100%) and acetamido-45 (80% from 37)
rhamnose analogues in equally high yields. It was not possible either to displace the triflates in 10 by any of a number of nucleophilic sources of fluoride (including TASF, TBAF and CsF) or to introduce fluorine directly by reaction of the alcohol 9 with DAST [35] or Xtalfluor [36] . [37] followed by acetylation with acetic anhydride in pyridine during the workup caused electrophilic fluorination to give a mixture of the four sugar triacetates 46α/β and 47 [Scheme 6] with little stereoselectivity. One of the 4 triacetates, the β-fluoro-rhamnose 46β, was isolated as a pure crystalline solid. Hydrolysis of 46β gave a pure sample of previously unknown 2-deoxy-2-fluoro-rhamnose 16 (27% overall yield) for biological evaluation. Hydrolysis of the mixture of 46α and 47α/β gave a mixture of fluororhamnose 16 and fluoro-quinovose 17 (38% yield); a pure sample of fluoro-quinovose 17 was obtained by preparative HPLC. 
The biotechnology of Izumoring [38] allows access to substantial amounts of rare deoxy sugars from rhamnose in water without the need for any protection. [39] Longer times of the reaction of 48 with IK7 gave oxidation of the (2S,3S) diol to form rhamnulose [6-deoxy-L-fructose] 49 (10%); [41] 49 was also be obtained by L-rhamnose isomerase (RI) equilibration with 1.
[30] DTagatose-3-epimerase (DTE) equilibrates all C3 epimeric pairs of deoxyketoses [40] and equilibrated 49
at C3 to give 6-deoxy-L-psicose 50. 41 Reaction of 50 with L-arabinose isomerase (AI) afforded 6-deoxy-L-altrose 18 allowing the ready preparation of 10 g of 18.
NMR analysis of synthetic free 6-deoxy-hexoses 1. 6-Deoxy-D-gulose 6 The synthesis and characterization, but not the NMR analysis, of 6-deoxy-D-gulose 6 has been reported. [23] 1 H and 13 C NMR spectra of 6 in D 2 O, pH=8.0, showed two spin-systems [ Table 1 ], confirmed as pyranose forms by the HMBC correlations between C1 and H5 (D-gulose also exists mainly in the pyranose form [42] ). The α and β pyranose anomers could be identified by the magnitude of coupling constant of anomeric proton (J 1,2 of β anomer was 8.3 Hz because of the trans-diaxial configuration; J 1,2 of α anomer was 3.0 Hz) and were present in an α-pyranose:β-pyranose ratio of 1:10. 6-Deoxy-α-L-talopyranose 6-Deoxy-β-L-talopyranose Table 2 ], confirmed as the pyranose and furanose forms by the HMBC correlations between C1 and H5 (pyranose) and H4 (furanose). The α-and β-anomers of the pyranose forms of 8 were identified from the ROESY spectra, the H1 of the β-anomer showing strong correlations with H3 and H5 whereas the H1 of the α-anomer only showed a strong correlation with H2 [ Figure 1 ]. The furanose forms were more difficult to analyze. The β-anomer was tentatively assigned on the basis of a stronger H1 to H2 ROESY correlation (SI). In addition, the 13 C data in this study agree with a previous report.
6-Deoxy-L-talose 8
[ 43] 3. 6-Deoxy-D-allose 7 The NMR data of 6-deoxy-β-D-allopyranose has been previously reported although in a different solvent.
[44] 1 H and 13 C NMR spectra of 6-deoxy-D-allose 7 in D 2 O, pH=6.1, showed four spin-systems [Table 3 ], confirmed as the pyranose and furanose forms by the HMBC correlations between H1 and C5 (pyranose) and C4 (furanose) (SI). The β-anomer of the pyranose forms was identified by the large trans-diaxial coupling between H1 and H2 and a strong ROESY correlation between H1 and H5 [ Figure 2 ] The analysis of furanose forms was more difficult. The β-anomer was tentatively assigned on the basis of a weak H1 to H4 ROESY correlation, not observed for the α-anomer.
Since 6-deoxy-β-D-allofuranose has an identical ring conformation to 6-deoxy-α-L-talofuranose (they only differ by the configuration at C5) [ Figure 2 ], the NMR parameters of the α-and β-furanose forms of 7 should be very similar to the β-and α-furanose forms 8 respectively. This provides additional support for the assignment of the furanose α-and β-anomers in 7 and 8. The ten L-gluco-series and L-manno-series targets synthesized from benzylidene protected Lrhamnonolactone 9, have similar NMR spectra to those of glucose and mannose.
L-gluco-analogues and L-manno-analogues
[45] [45c]
CONCLUSION
This paper describes the efficient production of 15 6-deoxy-sugars from L-rhamnose by a synergy of chemical synthesis and biotechnology as part of a project to find alternative non-metabolizable inducers to rhamnose for the L-rhamnose operon. Several inducers with different activities were identified: 1-deoxy-L-fructose 19 and 6-deoxy-L-altrose 18 were weak inducers; L-olivose 13 and 6-deoxy-2-fluoro-L-rhamnose 16 were moderate inducers. Further studies explored their induction kinetics and confirmed L-olivose 13, 6-deoxy-2-fluoro-L-rhamnose 16 and 6-deoxy-L-altrose 18 were poorly metabolized in E. coli. and gave sustained induction. [12] Such inducers with different strength could be used for different purposes e.g. production of toxic protein, production of certain protein in constant rate. Rhamnonolactones have rarely been used as chirons 46 but are ideal intermediates for the chemical modification of rhamnose. Full NMR characterization of several 6-deoxyhexoses has been provided for the first time.
EXPERIMENTAL SECTION

General Experimental
All commercial reagents were used as supplied. Solvents were used as supplied (Analytical or HPLC grade), without prior purification. Thin layer chromatography (TLC) was performed on aluminium sheets coated with 60 F 254 silica. Plates were visualised using a 0.2% w/v cerium (IV) sulfate and 5% ammonium molybdate solution in 2 M sulfuric acid. Melting points were recorded on a Kofler hot block and are uncorrected. Optical rotations of the protected sugars were recorded on a Perkin-Elmer 241 polarimeter with a path length of 1 dm; concentrations are quoted in g 100 mL -1 . Optical rotations were recorded on a Jasco R1030 polarimeter, Na + lamp, (Jasco, Tokyo, Japan) at 20 °C, polarimeter with a path length of 1 dm. Infrared spectra were recorded on a Perkin-Elmer 1750 IR Fourier Transform spectrophotometer using thin films on a diamond ATR surface (thin film). Only the characteristic peaks are quoted. Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker AMX 500 ( 
6-Deoxy-2,3-O-isopropylidene-L-lyxo-hex-5-ulosono-1,4-lactone 21
Dess-Martin periodinane (3.00 g, 6.80 mmol) was added in three portions to a solution of the alcohol 2 (1.10 g, 5.44 mmol) in dichloromethane (26 mL) at 0 °C. The reaction mixture was stirred at 0 °C for 2 h, after which TLC analysis (diethyl ether) revealed the absence of starting material (R f 0.6) and the formation of one major product (R f 0.8). The reaction mixture was filtered through Celite®, which was washed with dichloromethane (2 x 10 mL), and the liquids were concentrated in vacuo. The residue was then dissolved in dichloromethane (30 mL) and washed with sodium thiosulfate (sat. aq., 15 mL) and brine (15 mL). 
6-Deoxy-2,3-O-isopropylidene-D-gulose 3
Diisobutylaluminium hydride (25 % wt. in toluene, 1.17 mL, 2.04 mmol) was added dropwise to a solution of 6-deoxy-2,3-O-isopropylidene-D-gulono-1,4-lactone 22 (0.165 g, 0.82 mmol) in anhydrous DCM (2.4 mL) at -78 °C. The reaction mixture was stirred at -78 °C for 30 min, until TLC (hexane/ethyl acetate, 1:1) indicated the formation of one major product (R f 0.2). The reaction mixture was quenched with methanol and allowed to warm to rt. Ethyl acetate (2 mL), potassium dihydrogen orthophosphate (2 g) and sodium hydrogen carbonate (sat. aq., 2 mL) were added and the mixture was stirred for 10 min. The mixture was dried (anhydr. Na 2 SO 4 ), filtered through Celite ® , the solids were washed with ethyl acetate (3 x 10 mL) and the liquids were concentrated in vacuo. Flash column chromatography (hexane/ethyl acetate, 1:1) of the residue provided 6-deoxy-2,3-Oisopropylidene-D-gulose, 3 as a white solid (0.12 g, 75% 6-Deoxy-D-gulose 6 DOWEX ® 50WX8-100 (H + form) (0.07 g) was added into a solution of the lactols 3 (0.074 g, 0.36 mmol) in water (2 mL); after stirring at rt for 24 h, TLC analysis (hexane/ethyl acetate, 1:1.5) indicated the absence of the starting material (R f 0.5) and the formation of one polar major product (R f 0.0). The resin was filtered and washed with water (2 x 2 mL), the liquids were concentrated in vacuo and the residue was purified by column chromatography (methanol/dichloromethane, 1:6), to obtain a 10:1 mixture of β-and α-anomers of 6-deoxy-D-gulopyranose, 6 respectively (0.055 g, 93%), as a syrup.
[ 
6-Deoxy-2,3-O-isopropylidene-α-D-allose 4
Diisobutylaluminum hydride (25 % wt in toluene, 0.64 mL, 1.12 mmol) was added dropwise to a solution of the allono-lactone 24 (0.09 g, 0.45 mmol) in anhydrous dichloromethane (0.70 mL) at -78 °C. The reaction mixture was stirred at -78 °C for 30 min until TLC (hexane/ethyl acetate 1:1) indicated the comsumption of the starting material (R f 0.4) and formation of one major product (R f 0.3). The reaction was quenched with methanol and allowed to warm to rt. Ethyl acetate (2 mL), potassium dihydrogen orthophosphate (2 g) and sodium hydrogen carbonate (sat. aq., 2 mL) were added and the mixture was stirred for 10 min. 
6-Deoxy-2,3-O-isopropylidene-L-talose 5
Diisobutylaluminum hydride (25 % wt. in toluene, 3 mL, 5.23 mmol) was added dropwise to a solution of the talono-lactone 26 (0.5 g, 2.47 mmol) in anhydrous dichloromethane (7 mL) at -78 °C. The reaction mixture was stirred at -78 °C for 30 min, until TLC (hexane/ethyl acetate, 1:1) indicated the consumption of the starting material (R f 0.3) and formation of one major product (R f 0.4). The reaction was quenched with methanol and allowed to warm to rt. Ethyl acetate (2 mL), potassium dihydrogen orthophosphate (2 g) and sodium hydrogen carbonate (sat. aq., 2 mL) were added and the mixture was stirred for 10 min. The mixture was dried (anhydr. Na 2 SO 4 ) and filtered through Celite ® .
The solids were washed with ethyl acetate (3 x 10 mL) and the liquids concentrated in vacuo. 
6-Deoxy-2,3-O-isopropylidene-D-gulono-1,4-lactone 22 (from talono-lactone 26)
Methanesulfonyl chloride (0.1 mL, 1.28 mmol) and N,N-dimethylaminopyridine (0.013 g, 0.10 mmol) were added under argon to a solution of the talono-lactone 26 (0.21 g, 1.03 mmol) in anhydrous pyridine (1.4 mL) at 0 °C. The reaction mixture was stirred at 0 ºC for 3 h, when TLC (hexane/ethyl acetate, 1:1) showed the consumption of starting material (R f 0.3) and the formation of one reaction product (R f 0.4). The solvent was evaporated in vacuo and the residue co-evaporated with toluene (3 x 2 mL). The residue was dissolved in DCM (10 mL) and washed with water (5 mL) and brine (5 mL). Aqueous potassium hydroxide (0.60 M, 3.9 mL, 2.34 mmol) was added to a solution of crude mesylate 27 (0.22 g, 0.78 mmol) in 1,4-dioxane (5 mL) and the mixture was stirred at rt overnight. The reaction mixture was acidified to pH 1 with hydrochloric acid (2 M, aq.) and extracted with ethyl acetate (6 x 10 mL). TLC analysis (hexane/ethyl acetate, 1:1) indicated the transformation of the starting material (R f 0.4) into a mixture of lactone 22 (R f 0.2) and its carboxylic acid precursor (R f 0.0). The pooled organic extracts were stirred in presence of Na 2 SO 4 (anhydr.) at rt overnight, filtered and concentrated in vacuo. Flash column chromatography (ethyl acetate/hexane, 1:1) of the solid residue afforded the gulono-lactone 22 (0.12 g, 76%) as a white solid. This sample was identical to that prepared above from ketone 21 and was converted to 6-deoxy-D-gulose 6 as described above for biological evaluation. 
B. 2-Substituted
3,5-O-Benzylidene-2-O-tert-butyldimethylsilyl-6-deoxy-L-glucono-1,4-lactone 29
tert-Butyldimethylsilyl chloride (111 mg, 0.74 mmol) and imidazole (78 mg, 1.14 mmol) were added to a solution of 28 (143 mg, 0.57 mmol) in anhydrous DMF (3 mL). The reaction mixture was stirred at rt for 15 h until TLC (cyclohexane/ethyl acetate, 1:1) showed the formation of one major product (R f 0.8). Then the mixture was diluted with ethyl acetate (10 mL) and washed with half saturated brine (10 mL 
3,5-O-Benzylidene-2-O-tert-butyldimethylsilyl-6-deoxy-L-glucose 30
Diisobutylaluminium hydride (25% w/v in toluene, 0.30 mL, 0.53 mmol) was added dropwise to a solution of 29 (148 mg, 0.41 mmol) in anhydrous dichloromethane (3 mL) at -78 °C. The reaction mixture was stirred at -78°C for 1 h until mass spectrometry showed the formation of desired product peak and disappearance of starting material peak (m/z 364). Then the mixture was diluted with ethyl acetate (10 mL) and potassium sodium tartrate (sat. aq., ~0.5 mL) was added. After stirring for 8 h, the mixture was diluted with water (10 mL) and extracted with ethyl acetate (3 x 10 mL). Organic phase was dried (MgSO 4 ), filtered and solvent was removed in vacuo to obtain a residue that was further purified via flash chromatography (cyclohexane/ethyl acetate, 7:1→5:1) to yield the lactols 30 as a syrup (α:β ratio 5:4) (130 mg, 88%). in water (5 mL). After stirring at rt for 15 h mass spectrometry indicated the completion of reaction, the resin was filtered off and water was removed in vacuo to yield 6-deoxy-L-glucose 12 as a syrup (α:β ratio 3:5) (58 mg, 100%). 
3,5-O-Benzylidene-2,6-dideoxy-L-arabino-hexono-1,4-lactone 32
Lithium iodide hydrate (917 mg, 4.91 mmol) was added to a solution of triflate 10 (300 mg, 0.79 mmol) in butanone (10 mL). The reaction mixture was stirred at 60 °C for 16 h until TLC (cyclohexane/ethyl acetate, 1:1) showed the disappearance of starting material (R f 0.57) and formation of one major product (R f 0.39). Then sodium thiosulfate (sat. aq., sat, 10 mL) was added. After stirring at rt for 10 min, the reaction mixture was extracted with ethyl acetate (3 x 10 mL), the organic phase was dried (MgSO 4 ) and the solvent was removed in vacuo to give a residue which was purified by flash chromatography (cyclohexane/ethyl acetate, 4:1→1:1) to obtain the deoxylactone 32 (137 mg, 74%) as a white solid. 
3,5-O-Benzylidene-2,6-dideoxy-L-arabino-hexose 33
Diisobutylaluminium hydride (25% wt. in toluene, 0.32 mL, 0.56 mmol) was added dropwise to a solution of 32 (100 mg, 0.43 mmol) in anhydrous dichloromethane (4 mL) at -78 °C. The reaction mixture was stirred at -78 °C for 3 h until TLC (cyclohexane/ethyl acetate, 1:1) indicated the disappearance of starting material (R f 0.42) and the formation of one product (R f 0.49). Also mass spectrometry showed the formation of desired product peak (m/z 259). Then the mixture was diluted with ethyl acetate (5 mL) and potassium sodium tartrate (sat. aq., ~0.5 mL) was added. After stirring for 5 h, the mixture was diluted with water (5 mL) and extracted with ethyl acetate (3 x 5 mL). The organic phase was dried (MgSO 4 ), filtered and solvent was removed in vacuo to obtain a residue that was further purified via flash chromatography (cyclohexane/ethyl acetate 5:1 to 1:1) to yield the benzylidene lactols 33 as a white solid (α:β ratio 10:1) (96 mg, 96%). in water (5 mL). After stirring at rt for 18 h and mass spectrum indicated the completion of reaction, the resin was filtered off and water was removed in vacuo to yield L-olivose 13 as a syrup (α:β ratio 1:1) (56 mg, 100%). 
3,5-O-Benzylidene-2-azido-2,6-dideoxy-L-glucose 35
Diisobutylaluminium hydride (25% w/v in toluene, 0.34 mL, 0.60 mmol) was added dropwise to a solution of 34 (150 mg, 0.55 mmol) in anhydrous dichloromethane (5 mL) at -78 °C. The reaction mixture was stirred at -78 °C for 2 h until mass spectrometry showed the formation of desired product peak (m/z 300) and disappearance of starting material peak (m/z 298). Then the mixture was diluted with ethyl acetate (5 mL) and potassium sodium tartrate (sat. aq., ~0.5 mL) was added. After stirring for 5 h, the mixture was diluted with water (5 mL) and extracted with ethyl acetate (3 x 5 mL). The organic phase was dried (MgSO 4 ), filtered and solvent was removed in vacuo to obtain a crude product that was further purified via flash chromatography (cyclohexane/ethyl acetate 7:1) to yield the benzylidene lactol 35 as a colourless oil (α:β ratio 5:4) (126 mg, 84%). 
3,5-O-Benzylidene-2-azido-2, 6-dideoxy-L-mannose 37
Diisobutylaluminium hydride (25% w/v in toluene, 0.83 mL, 1.46 mmol) was added dropwise to a solution of 36 (310 mg, 1.13 mmol) in anhydrous dichloromethane (10 mL) at -78 °C. The reaction mixture was stirred at -78 °C for 3 h until TLC (cyclohexane/ethyl acetate, 1:1) indicated the consumption of starting material (R f 0.42) and the formation of one product (R f 0.50). Then the mixture was diluted with ethyl acetate (10 mL) and potassium sodium tartrate (sat. aq., ~1.0 mL) was added. After stirring for 5 h, the mixture was diluted with water (10 mL) and extracted with ethyl acetate (3 x 10 mL). Organic phase was dried (MgSO 4 ), filtered and solvent was removed in vacuo to obtain a crude that was further purified via flash chromatography (cyclohexane/ethyl acetate 3:1 to 1:1) to yield the lactol 37 as a white solid (α:β ratio 2:1) (270 mg, 87% 
2,6-Dideoxy-2-fluoro-L-glucose (2-Deoxy-2-fluoro-L-quinovose) 17
Trifluoroacetic acid (2.5 mL) was added to a solution of the mixture of 46α and 47α/β (200 mg, obtained from the preparation of 46β) in water (2.5 mL). The mixture was stirred at 60 °C for 12 h until mass spectrum showed the completion of the reaction. 
